Genelux Corporation (NASDAQ: GNLX) Stock Information | RedChip

Genelux Corporation (NASDAQ: GNLX) Listen to this Section


$2.03
-0.1000 ( -4.69% ) 60.6K

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Market Data


Open


$2.03

Previous close


$2.13

Volume


60.6K

Market cap


$69.39M

Day range


$2.02 - $2.16

52 week range


$1.60 - $30.44

Insider Ownership Transactions

Total Amount Purchased: -347,828.00 | $ -706,090.84

Date Type Amount Purchased Purchaser
2023-09-27 Sale -5200.00 Yu Yong
2023-09-27 Sale -3947.00 Szalay Aladar
2023-09-25 Sale -2871.00 Szalay Aladar
2023-09-21 Sale -6000.00 Yu Yong
2023-09-21 Sale -10000.00 Ryder Sean
2023-09-20 Sale -27365.00 Szalay Aladar
2023-09-18 Sale -2245.00 Thomas John
2023-09-18 Sale -10400.00 Yu Yong
2023-09-15 Sale -250000.00 Zindrick Thomas
2023-09-15 Sale -29800.00 Yu Yong

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Dec 14, 2023
8-k 8K-related 51 Dec 12, 2023
4 Insider transactions 1 Dec 08, 2023
8-k 8K-related 12 Nov 24, 2023
4 Insider transactions 1 Nov 22, 2023
4 Insider transactions 1 Nov 21, 2023
10-q Quarterly Reports 70 Nov 14, 2023
4 Insider transactions 1 Oct 26, 2023
4 Insider transactions 1 Oct 25, 2023
4 Insider transactions 1 Oct 25, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.